Maria G. Ghi

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Outcomes of different treatment patterns for adenoid cystic carcinoma of the anterior craniofacial area: A multi-institutional study on 578 patients.

Outcomes of different treatment patterns for adenoid cystic carcinoma of the anterior craniofacial area: A multi-institutional study on 578 patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 14, 2025

Clarifying the consensus on laryngeal preservation strategies - Authors' reply.

Clarifying the consensus on laryngeal preservation strategies - Authors' reply.

Journal: The Lancet. Oncology

Published: July 24, 2025

Erratum to "Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel" [Crit. Rev. Oncol. / Hematol. 210 (2025) 104709].

Erratum to "Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel" [Crit. Rev. Oncol. / Hematol. 210 (2025) 104709].

Journal: Critical reviews in oncology/hematology

Published: May 10, 2025

Selected laryngeal squamous cell carcinomas with laryngeal mobility impairment are suitable for curative larynx-preservation treatment: A multi-institutional study on 406 patients from the ARYFIX collaborative group.

Selected laryngeal squamous cell carcinomas with laryngeal mobility impairment are suitable for curative larynx-preservation treatment: A multi-institutional study on 406 patients from the ARYFIX collaborative group.

Journal: Oral oncology

Published: May 02, 2025

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Journal: JAMA

Published: March 13, 2025

Editorial: Understanding and treating rare nasal and paranasal sinus cancers.

Editorial: Understanding and treating rare nasal and paranasal sinus cancers.

Journal: Frontiers in oncology

Published: February 09, 2025

Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel.

Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel.

Journal: Critical reviews in oncology/hematology

Published: November 25, 2024

International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer.

International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer.

Journal: The Lancet. Oncology

Published: November 15, 2024

Corrigendum to "How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group" [Oral Oncol. 152C (2024) 106744].

Corrigendum to "How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group" [Oral Oncol. 152C (2024) 106744].

Journal: Oral oncology

Published: June 09, 2024

How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group.

How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group.

Journal: Oral oncology

Published: January 10, 2024

Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.

Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.

Journal: Journal for immunotherapy of cancer

Published: December 19, 2023

Dosiomic-based prediction of dysgeusia in head & neck cancer patients treated with radiotherapy.

Dosiomic-based prediction of dysgeusia in head & neck cancer patients treated with radiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 06, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026